Floatz logo

WARFARIN

Status; Splenectomy

Yangzhou UniversitySmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Status; Splenectomy cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Yangzhou University
Phase 4BB
Dipyridamole
Yangzhou University
Phase 4BB
Desflurane
Theodor Bilharz Research Institute
N/AD
PROPOFOL
Theodor Bilharz Research Institute
N/AD

Same molecule, other indications

WARFARIN is also rated in:

venous thromboembolismDormant
A
Indicative ·
81 / 100
View asset →
atrial fibrillationDormant
BBB
Indicative ·
77 / 100
View asset →
hemorrhagic diseaseDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →